Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Baxter International Inc.    BAX

BAXTER INTERNATIONAL INC.

(BAX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/19/2020 10/20/2020 10/21/2020 10/22/2020 10/23/2020 Date
81.19(c) 81.14(c) 81.74(c) 81.45(c) 81.09(c) Last
2 627 933 3 191 637 2 788 117 1 933 816 1 649 202 Volume
-0.77% -0.06% +0.74% -0.35% -0.44% Change
More quotes
Financials (USD)
Sales 2020 11 422 M - -
Net income 2020 1 399 M - -
Net Debt 2020 1 401 M - -
P/E ratio 2020 30,1x
Yield 2020 1,18%
Sales 2021 12 103 M - -
Net income 2021 1 775 M - -
Net Debt 2021 745 M - -
P/E ratio 2021 23,6x
Yield 2021 1,33%
Capitalization 41 050 M 41 050 M -
EV / Sales 2020 3,72x
EV / Sales 2021 3,45x
Nbr of Employees 50 000
Free-Float 74,4%
More Financials
Company
Baxter International specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - kidney dialysis drugs and equipment (52.1%); - systems for delivering medications and intravenous therapy (24.6%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral... 
More about the company
Notations Surperformance© of Baxter International Inc.
Trading Rating : Investor Rating :
More Ratings
All news about BAXTER INTERNATIONAL INC.
10/16BAXTER INTERNATIONAL : to Present at 29th Annual Credit Suisse Virtual Healthcar..
AQ
10/16BAXTER INTERNATIONAL : Supports New Study Showing Nutritional Needs in Criticall..
BU
10/15BAXTER INTERNATIONAL : to Present at 29th Annual Credit Suisse Virtual Healthcar..
PU
10/15BAXTER INTERNATIONAL : to Present at the 29th Annual Credit Suisse Virtual Healt..
BU
10/14BAXTER INTERNATIONAL : Supports New Study Showing Nutritional Needs in Criticall..
BU
10/08BAXTER INTERNATIONAL INC : Regulation FD Disclosure (form 8-K)
AQ
09/28BAXTER INTERNATIONAL INC : Regulation FD Disclosure (form 8-K)
AQ
09/25BAXTER INTERNATIONAL INC : Change in Directors or Principal Officers (form 8-K)
AQ
09/23BAXTER INTERNATIONAL : Gets FDA OK of Higher-Protein Clinimix, Clinimix E Formul..
DJ
09/23BAXTER INTERNATIONAL :  Baxter Announces U.S. FDA Approval of Clinimix and Clini..
BU
09/18BAXTER INTERNATIONAL : RNLI and BT announce new partnership to help save lives
PU
09/17BAXTER INTERNATIONAL : Announces Exclusive Distribution Agreement with bioMerieu..
AQ
09/16BAXTER INTERNATIONAL : Announces Exclusive Distribution Agreement With bioMérieu..
BU
09/10BAXTER INTERNATIONAL : to Host Third-Quarter 2020 Financial Results Conference C..
AQ
09/09BAXTER INTERNATIONAL : to Host Third-Quarter 2020 Financial Results Conference C..
PU
More news
News in other languages on BAXTER INTERNATIONAL INC.
10/16BAXTER INTERNATIONAL : soutient une nouvelle étude montrant les besoins nutritio..
10/16BAXTER INTERNATIONAL : unterstützt neue Studie zur Aufzeigung von Ernährungsbedü..
07/29TAGESVORSCHAU : Termine am 30. Juli 2020
07/27BAXTER INTERNATIONAL INC. : Veröffentlichung des Halbjahresergebnisses
07/27BAXTER INTERNATIONAL INC. : publication des résultats semestriels
More news
Chart BAXTER INTERNATIONAL INC.
Duration : Period :
Baxter International Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAXTER INTERNATIONAL INC.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 19
Average target price 94,44 $
Last Close Price 81,09 $
Spread / Highest target 29,5%
Spread / Average Target 16,5%
Spread / Lowest Target -9,98%
EPS Revisions
Managers
NameTitle
José E. Almeida Chairman, President & Chief Executive Officer
James K. Saccaro Chief Financial Officer & Executive Vice President
Sumant Ramachandra Senior VP, Chief Science & Technology Officer
Tobi Karchmer Vice President-Worldwide Medical
Talvis Love Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
BAXTER INTERNATIONAL INC.-3.03%41 050
ABBOTT LABORATORIES24.10%190 845
MEDTRONIC PLC-1.79%149 794
BECTON, DICKINSON AND COMPANY-11.65%69 650
HOYA CORPORATION14.02%42 617
DEXCOM, INC.87.89%39 350